Marine microorganisms have emerged as prolific sources of bioactive natural products, offering a large chemical diversity and a broad spectrum of biological activities. Over the past decade, significant progress has been made in discovering and characterizing these compounds, pushed by technological innovations in genomics, metabolomics, and bioinformatics. Furthermore, innovative isolation and cultivation approaches have improved the isolation of rare and difficult-to-culture marine microbes, leading to the identification of novel secondary metabolites. Advances in synthetic biology and metabolic engineering have further optimized natural product yields and the generation of novel compounds with improved bioactive properties. This review highlights key developments in the exploitation of marine bacteria, fungi, and microalgae for the discovery of novel natural products with potential applications in diverse fields, underscoring the immense potential of marine microorganisms in the growing Blue Economy sector.

Over the past years, with the growing interest in sustainable biomaterials, marine collagen has been emerging as an interesting alternative to bovine collagen. It is more easily absorbed by the body and has higher bioavailability. In this study, collagen was extracted from Dicentrarchus labrax (sea bass) skin, a fishery by-product, thus valorizing waste streams while reducing environmental impact. To overcome the intrinsic weak mechanical of collagen, it was combined with chitosan to produce composite scaffolds for skin tissue engineering. The incorporation of collagen proved crucial for scaffold performance: (i) it promoted the formation of an open-pore architecture, favorable for cell infiltration and proliferation; (ii) it enhanced swelling behavior suitable for exudate absorption and maintenance of a moist wound environment; (iii) by tuning the chitosan/collagen ratio, it enabled us to control the degradation rate; (iv) it conferred antioxidant properties; and (iv) by adjusting collagen/chitosan concentrations, it allowed fine-tuning of mechanical properties, ensuring sufficient strength to resist stresses encountered during wound healing. In vitro assays demonstrated that the scaffolds were non-cytotoxic and effectively supported mouse adipose tissue fibroblasts’ adhesion and proliferation. Finally, all formulations exhibited marked bactericidal activity against the human pathogen Staphylococcus aureus and the methicillin-resistant Staphylococcus aureus, with a Log reduction greater than 3 (a reduction of at least 99.9% in bacterial growth) compared to the control. Collectively, these findings highlight collagen not only as a sustainable resource but also as a functional component that drives the structural, physicochemical, biological, and antimicrobial performance of chitosan/collagen scaffolds for skin tissue engineering.

Coral reef survival is crucial for the socio-ecological interest of many countries, particularly for the Republic of Maldives, whose reef integrity influences the country’s livelihoods and economy. These ecosystems are being severely impacted by multiple stressors, leading to declines in biodiversity. In the last few decades, researchers have focused on studying coral-associated microorganisms (CAMs) and their symbiotic role in coral health and resilience. Metabarcoding analysis has been widely utilized to study CAM diversity under various conditions but provides limited information on their functional roles. Therefore, cultivation of bacterial strains remains indispensable for validating ecological and biotechnological hypotheses. In this study, we investigated the microbial community associated with two abundant corals in Maldives, Porites lobata and Acropora gemmifera, and evaluated the antimicrobial, antioxidant, and UV-protectant properties of 10 promising isolated strains. The selected CAMs, Pseudoalteromonas piscicida 39, Streptomyces parvus 79, Microbacterium sp. 92 (a potential novel species), and Micromonospora arenicola 93, exhibited antibiotic activity against a panel of pathogenic strains (MIC from 0.01 to 500 µg/mL), antioxidant (comparable effect to that of Trolox and ascorbic acid), and UV-screen activities (protection of human keratinocytes at 200 µg/mL). Genomes revealed their dual potential in contributing to coral restoration and drug discovery strategies. These findings highlight the biotechnological relevance of CAMs, representing an important step toward the identification of novel and bioactive bacterial species beneficial for coral reef ecosystems and human health.

Enzymatic hydrolysis is one of the effective methods used to obtain the bioactive peptides from marine resources. This study aimed to evaluate effect of the enzyme type (Food Pro PNL (FP), Corolase8000 (C8), and Corolase7089 (C7)) and biomass pretreatment level (whole starfish (SF), deproteinized (DPSF) as well as deproteinized and demineralized starfish (DPDMSF)) on the hydrolysate yield, degree of hydrolysis (DH), generated peptides’ molecular weight (MW), and in vitro radical scavenging and antiproliferative effects. Regardless of the enzyme used, deproteinization reduced the hydrolysate yield (<8% dw/ww) and DH (40%) to SF. However, the protein content of hydrolysates from DPSF and DPDMSF was higher than that prepared from SF. C8 was not effective in hydrolyzing SF but was the only effective enzyme in hydrolyzing DPDMSF. The peptides’ MW distribution strongly depended on the pretreatment and enzyme type, mostly ranging from 17 to 70 kDa. Glycine content was higher in hydrolysates from DPSF and DMDPSF, indicating their collagenous nature. Hydrolysates from DPSF, rich in collagenous peptides, showed medium MW but the highest radical scavenging activity. Only SF-FP hydrolysate, rich in non-collagenous peptides, showed antiproliferative activity against melanoma cancer cells. Overall, the findings demonstrate that upstream biomass pretreatment and enzyme selection directly govern the yield and bioactivity of starfish protein hydrolysates, providing a rational basis for designing starfish protein hydrolysates with targeted functional properties.

Microalgae are extremely diverse photosynthetic organisms, adapted to live in different habitat conditions, from freshwater to marine environments. This adaptability is also associated with the ability to produce several metabolites. Polyunsaturated aldehydes (PUAs), first identified in 1999 in Thalassiosira gravida and Skeletonema costatum, are known to influence the development of their predators, having teratogenic effects and blocking their development. PUAs have shown several activities, such as antitumor, antimicrobial and antiparasite. Another relevant compound is pheophorbide a (PPBa), a chlorophyll degradation product, which has previously shown properties useful to be considered as a photosensitizer in photodynamic therapy, demonstrating cytotoxic effects on various tumor cell lines. It has also been shown to have activity against some bacteria and fungi. Considering the growing problem of multi-antibiotic resistance of human pathogenic bacteria and the increasing market demand for new drugs, the aim of our work was to screen two PUAs, i. e., 2,4-octadienal and trans,trans-2,4-decadienal, and PPBa against a panel of human pathogenic bacteria and fungi: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans and Aspergillus fumigatus. The antimicrobial activity was evaluated through MIC (Minimum Inhibitory Concentration) and MFC/MBC (Minimum Fungicidal/Bactericidal Concentration), demonstrating that the two PUAs had a greater antimicrobial activity than PPBa on both bacteria and fungi, except for P. aeruginosa, where the antimicrobial activity was low. The compound 2,4-Octadienal showed extremely high antifungal activity, especially against the fungus A. fumigatus, where the MIC and MFC were 0.001 µL/mL and 0.004 µL/mL, respectively. These results are shedding light on the antimicrobial activity of microalgal compounds and their possible applications for different human infection diseases.

The increasing incidence of jellyfish blooms and the consequent accumulation of jellyfish bycatch impose the need to explore new strategies for the valorization of this marine biomass. Jellyfish are attracting growing interest as sustainable sources of proteins, collagen, and bioactive peptides with potential applications in food, nutraceutical, and biotechnological fields. In this work, the Mediterranean jellyfish Cotylorhiza tuberculata was investigated as a source of proteinaceous fractions and enzymatic hydrolysates. Umbrella and oral arms were processed separately by phosphate-buffered saline (PBS) extraction, followed by sequential enzymatic digestion of the insoluble material with pepsin and collagenase. The resulting extracts were fractionated by membrane ultrafiltration and characterized for protein content. The fractions were then tested for antioxidant activity, angiotensin-I-converting enzyme (ACE) inhibition, effects on A2058 melanoma and HaCaT keratinocyte viability, and modulation of IL-6 response in intestinal Caco-2 cells. Collagenase-derived fractions showed the highest antioxidant activity, while ACE-inhibitory activity was mainly associated with pepsin-derived samples. Selected umbrella-derived fractions differentially affected A2058 and HaCaT cell viability. Finally, preliminary Caco-2 experiments indicated limited, fraction-dependent modulation of IL-6 levels. Overall, these results suggest that C. tuberculata may represent a useful source of protein-derived fractions with in vitro antioxidant and ACE-inhibitory activities, supporting further investigation of jellyfish bycatch as a resource for functional ingredients.